Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) is a blank-check company focused on the biotechnology and life sciences sector that completed its initial public offering in 2021. The company filed its Form 10-K annual report with the SEC on March 29, 2023, covering the fiscal year ended December 31, 2022, indicating it remained in the business combination search phase through the close of that period. ORIA was formed to identify and execute a merger or acquisition with a target operating in biopharmaceuticals, medical devices, diagnostics, or adjacent healthcare verticals. Readers seeking sponsor details, deal timelines, and complete filing history for ORIA can sign up for full data access at SpacDesk.